Dimethocaine: Exploring the Metabolic Pathways of a Synthetic Cocaine Derivative
Dimethocaine metabolism involves P450 enzymes, especially P450 3A4 and 2D6 for hepatic clearance, and NAT2 for crucial N-acetylation, highlighting its complex biotransformation.
Feb 6，2024 API
Regorafenib for the Treatment of Sarcoma
Regorafenib shows promise in treating sarcomas by targeting multiple pathways and improving progression-free survival, with manageable side effects like hypertension and hand-foot skin reaction.
Feb 6，2024 API
Adverse Reactions to Ornidazole: Liver Damage and Fixed Drug Reactions
Ornidazole can cause severe liver damage and fixed drug reactions, necessitating prompt recognition and withdrawal for appropriate management.
Feb 6，2024 API
Apalutamide: A Promising Pharmacodynamic Drug for Prostate Cancer Treatment
Apalutamide inhibits prostate cancer growth, decreases tumor volume, and exhibits dose-proportional pharmacokinetics. Adverse events include fatigue, hypertension, rash, and fractures.
Feb 6，2024 API
Ronidazole: A Potent Antiprotozoal with Carcinogenic Concerns
Ronidazole is a potent antiprotozoal medication used to treat trichomonal and Giardia infections. It may cause side effects such as vomiting and neurological signs.
Feb 6，2024 API
Deflazacort: A Glucocorticoid Prodrug for the Treatment of Duchenne Muscular Dystrophy
Deflazacort is a glucocorticoid prodrug used in DMD, with anti-inflammatory effects and potential muscle-related benefits. Safety concerns include adverse effects and drug interactions.
Feb 6，2024 API
Paliperidone: A Safe and Effective Treatment Option for Schizophrenia and Schizoaffective Disorder
Paliperidone is an effective and well-tolerated treatment for schizophrenia, with benefits in symptom reduction, relapse prevention, and cognitive improvement.
Feb 6，2024 API
Exploring Glucagon's Role in Insulin Secretion and its Implications for Diabetes Treatment
Glucagon's role in insulin secretion can be targeted with GCGR antagonists and GLP-1R agonists for diabetes treatment.
Feb 6，2024 API
Entecavir: Highly Effective Antiviral Drug for Hepatitis B Treatment
Entecavir is an effective antiviral for chronic hepatitis B, inhibiting viral replication. Side effects are mild, and resistance can occur in non-naive patients.
Feb 6，2024 API
Crisaborole: A Boron-Containing Molecule with Therapeutic Efficacy in Treating Atopic Dermatitis
Crisaborole inhibits PDE4, increasing cAMP levels, with well-tolerated topically and minimally absorbed systemically. Effective in treating atopic dermatitis by reducing inflammation.
Feb 6，2024 API